North Star Investment Management Corp. - PSYCHEMEDICS CORP ownership

PSYCHEMEDICS CORP's ticker is PMD and the CUSIP is 744375205. A total of 26 filers reported holding PSYCHEMEDICS CORP in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
North Star Investment Management Corp. ownership history of PSYCHEMEDICS CORP
ValueSharesWeighting
Q1 2023$656
+7.0%
1250.0%0.00%
Q4 2022$613
-38.7%
1250.0%0.00%
Q3 2022$1,0000.0%1250.0%0.00%
Q2 2022$1,0000.0%1250.0%0.00%
Q1 2022$1,000
-85.7%
125
-87.5%
0.00%
Q4 2021$7,000
-12.5%
1,0000.0%0.00%
-100.0%
Q3 2021$8,000
+14.3%
1,0000.0%0.00%0.0%
Q2 2021$7,000
+16.7%
1,0000.0%0.00%0.0%
Q1 2021$6,000
+20.0%
1,0000.0%0.00%0.0%
Q4 2020$5,000
-98.0%
1,000
-98.2%
0.00%
-96.6%
Q3 2020$246,000
-21.7%
55,850
-1.5%
0.03%
-29.3%
Q2 2020$314,000
-11.3%
56,675
-3.1%
0.04%
-21.2%
Q1 2020$354,000
-35.2%
58,475
-2.1%
0.05%
-8.8%
Q4 2019$546,000
-25.2%
59,700
-25.5%
0.06%
-29.6%
Q3 2019$730,000
-14.8%
80,119
-5.7%
0.08%
-18.2%
Q2 2019$857,000
-28.1%
84,956
+0.0%
0.10%
-28.8%
Q1 2019$1,192,000
-11.9%
84,948
-0.4%
0.14%
-21.5%
Q4 2018$1,353,000
-11.5%
85,282
+4.9%
0.18%
+3.5%
Q3 2018$1,529,000
+3.7%
81,277
+6.1%
0.17%0.0%
Q2 2018$1,474,000
-15.0%
76,623
-5.6%
0.17%
-17.4%
Q1 2018$1,734,000
+4.0%
81,194
+0.1%
0.21%
+2.5%
Q4 2017$1,668,000
+15.6%
81,150
+3.7%
0.20%
+10.4%
Q3 2017$1,443,000
-25.0%
78,271
+1.5%
0.18%
-28.8%
Q2 2017$1,923,000
+35.0%
77,085
+8.5%
0.26%
+31.1%
Q1 2017$1,424,000
-19.8%
71,032
-1.3%
0.20%
-26.6%
Q4 2016$1,776,000
-20.1%
71,979
-35.8%
0.27%
-32.4%
Q3 2016$2,224,000
-24.4%
112,202
-47.6%
0.40%
-27.0%
Q2 2016$2,941,000
+1.2%
214,049
+1.3%
0.54%
-2.9%
Q1 2016$2,906,000
+36.9%
211,370
+0.9%
0.56%
+34.9%
Q4 2015$2,123,000
+8.2%
209,395
+7.2%
0.41%
+2.5%
Q3 2015$1,963,000
+17.2%
195,320
+72.9%
0.40%
+30.8%
Q2 2015$1,675,000
-10.4%
112,950
+0.2%
0.31%
-12.0%
Q1 2015$1,870,000
+15.1%
112,700
+5.1%
0.35%
+12.9%
Q4 2014$1,624,000
+7.7%
107,200
+0.7%
0.31%
+2.6%
Q3 2014$1,508,000
+9.0%
106,475
+9.0%
0.30%
+8.6%
Q2 2014$1,383,000
-15.9%
97,650
+1.8%
0.28%
-19.0%
Q1 2014$1,644,000
+25.5%
95,950
+7.6%
0.34%
+20.4%
Q4 2013$1,310,000
+11.8%
89,150
+0.8%
0.28%
-8.9%
Q3 2013$1,172,000
+54.0%
88,450
+24.8%
0.31%
+58.9%
Q2 2013$761,00070,9000.20%
Other shareholders
PSYCHEMEDICS CORP shareholders Q1 2022
NameSharesValueWeighting ↓
WEALTH EFFECTS LLC 44,501$218,2630.12%
Cannell Capital 74,794$366,8420.07%
SANTA MONICA PARTNERS LP 20,000$980.07%
RBF Capital, LLC 144,231$707,0000.05%
CRAWFORD INVESTMENT COUNSEL INC 257,795$1,264,4050.03%
Ancora Advisors LLC 70,916$3480.01%
WEDBUSH SECURITIES INC 30,928$1520.01%
Renaissance Technologies 290,463$1,4250.00%
GEODE CAPITAL MANAGEMENT, LLC 35,206$1730.00%
NORTHERN TRUST CORP 17,030$83,5270.00%
View complete list of PSYCHEMEDICS CORP shareholders